International Journal of Urology最新文献

筛选
英文 中文
Editorial Comment to Niraparib With Abiraterone Acetate Plus Prednisone as First-Line Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Repair Gene Alterations: Final Analysis of the Asian Subgroup From the MAGNITUDE Study. 尼拉帕尼联合醋酸阿比特龙加强的松作为转移性阉割抵抗性前列腺癌同源重组修复基因改变患者的一线治疗:来自量级研究的亚洲亚组的最终分析
IF 2.2 3区 医学
International Journal of Urology Pub Date : 2026-05-01 DOI: 10.1111/iju.70488
Yoshiyuki Miyazawa
{"title":"Editorial Comment to Niraparib With Abiraterone Acetate Plus Prednisone as First-Line Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Repair Gene Alterations: Final Analysis of the Asian Subgroup From the MAGNITUDE Study.","authors":"Yoshiyuki Miyazawa","doi":"10.1111/iju.70488","DOIUrl":"https://doi.org/10.1111/iju.70488","url":null,"abstract":"","PeriodicalId":14323,"journal":{"name":"International Journal of Urology","volume":"33 5","pages":"e70488"},"PeriodicalIF":2.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147771208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of the Trend in Timing of Surgery for Cryptorchidism: Has Earlier Surgical Intervention Been Achieved. 隐睾手术时机的趋势评估:早期手术干预是否已经实现。
IF 2.2 3区 医学
International Journal of Urology Pub Date : 2026-05-01 DOI: 10.1111/iju.70475
Taiju Hyuga, Koki Sugimura, Tatsuya Muto, Kimihiko Moriya
{"title":"Assessment of the Trend in Timing of Surgery for Cryptorchidism: Has Earlier Surgical Intervention Been Achieved.","authors":"Taiju Hyuga, Koki Sugimura, Tatsuya Muto, Kimihiko Moriya","doi":"10.1111/iju.70475","DOIUrl":"https://doi.org/10.1111/iju.70475","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to investigate age at surgery for cryptorchidism and to identify factors associated with early surgery.</p><p><strong>Methods: </strong>This retrospective study investigated 664 cases of cryptorchidism treated surgically between 2007 and 2023. Early surgery was defined as surgery at less than 1 year old. The cases detected at birth or at the 1-month checkup were defined as early detected cases and age at initial visit less than 6 months old was defined as early initial visit.</p><p><strong>Results: </strong>The proportion of early surgery increased over time, from 6.3% in 2007-2011 to 30.9% in 2020-2023 (OR 1.67, 95% CI 1.39-2.02; p < 0.001). Multivariate analyses demonstrated that early initial visit, era of surgery, hypospadias and multiple congenital anomalies were independently associated with early surgery. Among 200 early detected cases, 55.5% of these had delayed initial visits (at or over 6 months old). In early detected cases, multivariate analysis demonstrated that the shorter intervals from detection to initial visit and from surgical plan to the date of surgery were independently associated with early surgery. Even among early detected and early visiting cases, some surgeries were delayed due to patient-related factors.</p><p><strong>Conclusions: </strong>Age at initial visit is getting earlier, and surgery for cases less than 1 year old is also increasing, but remains insufficient. To achieve earlier surgical intervention for cryptorchidism, an early initial visit is essential. When findings suggestive of cryptorchidism are identified, immediate referral is crucial, and further observation is unnecessary.</p>","PeriodicalId":14323,"journal":{"name":"International Journal of Urology","volume":"33 5","pages":"e70475"},"PeriodicalIF":2.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147771239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Comment on "Comparison of Infectious Complications After Transrectal Prostate Biopsy Under Two Antibiotic Prophylaxis Regimens: Ceftriaxone Plus Cefixime Versus Ciprofloxacin Plus Gentamicin". 关于“头孢曲松加头孢克肟与环丙沙星加庆大霉素两种抗生素预防方案下经直肠前列腺活检后感染并发症的比较”的社论评论。
IF 2.2 3区 医学
International Journal of Urology Pub Date : 2026-05-01 DOI: 10.1111/iju.70466
Shirin Razdan
{"title":"Editorial Comment on \"Comparison of Infectious Complications After Transrectal Prostate Biopsy Under Two Antibiotic Prophylaxis Regimens: Ceftriaxone Plus Cefixime Versus Ciprofloxacin Plus Gentamicin\".","authors":"Shirin Razdan","doi":"10.1111/iju.70466","DOIUrl":"https://doi.org/10.1111/iju.70466","url":null,"abstract":"","PeriodicalId":14323,"journal":{"name":"International Journal of Urology","volume":"33 5","pages":"e70466"},"PeriodicalIF":2.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147771241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaginal Flap Urethroplasty and Dorsal Onlay Buccal Mucosal Graft Urethroplasty for Female Urethral Stricture: A Single-Center Experience. 阴道皮瓣尿道成形术和背侧颊粘膜移植尿道成形术治疗女性尿道狭窄:单中心经验。
IF 2.2 3区 医学
International Journal of Urology Pub Date : 2026-05-01 DOI: 10.1111/iju.70477
Madoka Higuchi, Akio Horiguchi, Misaki Ashiya, Yuhei Segawa, Kazuki Yanagida, Daisuke Watanabe, Kenichiro Ojima, Masayuki Shinchi, Keiichi Ito
{"title":"Vaginal Flap Urethroplasty and Dorsal Onlay Buccal Mucosal Graft Urethroplasty for Female Urethral Stricture: A Single-Center Experience.","authors":"Madoka Higuchi, Akio Horiguchi, Misaki Ashiya, Yuhei Segawa, Kazuki Yanagida, Daisuke Watanabe, Kenichiro Ojima, Masayuki Shinchi, Keiichi Ito","doi":"10.1111/iju.70477","DOIUrl":"https://doi.org/10.1111/iju.70477","url":null,"abstract":"<p><strong>Objective: </strong>Female urethral stricture (FUS) is a rare pathology often managed with ineffective repetitive transurethral treatments. Although guidelines recommend urethroplasty, high-quality evidence remains scarce due to the limited number of reported cases. We reviewed our institutional series to compare the surgical and functional outcomes between vaginal flap urethroplasty (VFU) and dorsal onlay buccal mucosal graft urethroplasty (DOBMGU), aiming to clarify the optimal surgical strategy.</p><p><strong>Methods: </strong>We retrospectively reviewed 15 female patients undergoing urethroplasty at a single center between 2012 and 2025. VFU was mainly indicated for strictures confined to the distal urethra, whereas DOBMGU was applied to strictures involving any anatomical segment. Surgical success was strictly defined as the absence of anatomical re-stricture on cystoscopy without secondary interventions.</p><p><strong>Results: </strong>VFU was performed in 7 (46.7%) and DOBMGU in 8 (53.3%). The DOBMGU group comprised distal (n = 2), mid-to-proximal (n = 3), and pan-urethral (n = 3) strictures. At a median follow-up of 12 months, DOBMGU achieved a higher success rate (87.5%, 7/8) compared to VFU (57.1%, 4/7). Both groups showed significant improvement in maximum urinary flow rate (p < 0.05). Notably, all 7 patients presenting with preoperative urinary retention achieved catheter-free status. De novo incontinence was rare (n = 1), while urinary spraying was noted only in the VFU group (n = 2).</p><p><strong>Conclusion: </strong>While VFU remains a valid option for distal strictures, DOBMGU demonstrated highly favorable functional reliability and anatomical stability, regardless of stricture location. Urethroplasty is a definitive treatment for FUS, offering high success rates and preservation of urinary continence.</p>","PeriodicalId":14323,"journal":{"name":"International Journal of Urology","volume":"33 5","pages":"e70477"},"PeriodicalIF":2.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147771328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Comment on Midterm Outcomes of Combination Therapy With Immune Checkpoint Inhibitors and VEGFR-TKIs in Real-World Patients With Advanced Renal Cell Carcinoma. 免疫检查点抑制剂和VEGFR-TKIs联合治疗现实世界晚期肾细胞癌患者的中期结果
IF 2.2 3区 医学
International Journal of Urology Pub Date : 2026-05-01 DOI: 10.1111/iju.70480
Hiroshi Fukushima, Soichiro Yoshida, Yasuhisa Fujii
{"title":"Editorial Comment on Midterm Outcomes of Combination Therapy With Immune Checkpoint Inhibitors and VEGFR-TKIs in Real-World Patients With Advanced Renal Cell Carcinoma.","authors":"Hiroshi Fukushima, Soichiro Yoshida, Yasuhisa Fujii","doi":"10.1111/iju.70480","DOIUrl":"https://doi.org/10.1111/iju.70480","url":null,"abstract":"","PeriodicalId":14323,"journal":{"name":"International Journal of Urology","volume":"33 5","pages":"e70480"},"PeriodicalIF":2.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147771163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Comment to Real-World Outcomes After Radical Cystectomy for Muscle-Invasive Bladder Cancer in Japan: A Nationwide Descriptive Study From the National Clinical Database. 编辑评论:日本肌肉浸润性膀胱癌根治性膀胱切除术后的真实世界结果:一项来自国家临床数据库的全国性描述性研究。
IF 2.2 3区 医学
International Journal of Urology Pub Date : 2026-05-01 DOI: 10.1111/iju.70481
Makito Miyake
{"title":"Editorial Comment to Real-World Outcomes After Radical Cystectomy for Muscle-Invasive Bladder Cancer in Japan: A Nationwide Descriptive Study From the National Clinical Database.","authors":"Makito Miyake","doi":"10.1111/iju.70481","DOIUrl":"https://doi.org/10.1111/iju.70481","url":null,"abstract":"","PeriodicalId":14323,"journal":{"name":"International Journal of Urology","volume":"33 5","pages":"e70481"},"PeriodicalIF":2.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147771237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extent of Pelvic Lymph Node Dissection at Partial Cystectomy: Effect on Cancer-Specific Mortality. 部分膀胱切除术时盆腔淋巴结清扫的范围:对肿瘤特异性死亡率的影响。
IF 2.2 3区 医学
International Journal of Urology Pub Date : 2026-05-01 DOI: 10.1111/iju.70483
Mattia Longoni, Andrea Marmiroli, Fabian Falkenbach, Quynh Chi Le, Michele Nicolazzini, Calogero Catanzaro, Federico Polverino, Jordan A Goyal, Markus Graefen, Gennaro Musi, Felix K H Chun, Carlotta Palumbo, Riccardo Schiavina, Nicola Longo, Fred Saad, Shahrokh F Shariat, Marco Moschini, Giorgio Gandaglia, Francesco Montorsi, Alberto Briganti, Pierre I Karakiewicz
{"title":"Extent of Pelvic Lymph Node Dissection at Partial Cystectomy: Effect on Cancer-Specific Mortality.","authors":"Mattia Longoni, Andrea Marmiroli, Fabian Falkenbach, Quynh Chi Le, Michele Nicolazzini, Calogero Catanzaro, Federico Polverino, Jordan A Goyal, Markus Graefen, Gennaro Musi, Felix K H Chun, Carlotta Palumbo, Riccardo Schiavina, Nicola Longo, Fred Saad, Shahrokh F Shariat, Marco Moschini, Giorgio Gandaglia, Francesco Montorsi, Alberto Briganti, Pierre I Karakiewicz","doi":"10.1111/iju.70483","DOIUrl":"https://doi.org/10.1111/iju.70483","url":null,"abstract":"<p><strong>Introduction: </strong>We assessed the extent of pelvic lymph node dissection (PLND) at partial cystectomy (PC) according to PC eligibility (≤cT2 stage, tumor ≤ 3 cm and segmental resection possible) and tested its effect on cancer-specific mortality (CSM).</p><p><strong>Methods: </strong>Within the SEER database (2004-2021), we identified PC patients undergoing PLND and tabulated the number of lymph nodes (LNs) removed according to PC eligibility. Multivariable Cox-regression models tested the effect of PLND extent on CSM after adjusting for age, sex, T stage, N stage, and chemotherapy.</p><p><strong>Results: </strong>Of 1017 PC patients undergoing PLND, 197 (19.4%) were eligible vs. 820 (80.6%) ineligible according to PC eligibility criteria. Median number of LNs removed at PLND was 6 (IQR: 3-11) in eligible versus 7 (IQR: 3-14) in ineligible patients (p = 0.09). Mean numbers of LNs removed at PLND increased over the study period, from 7 to 16 (p = 0.007) in PC-eligible and from 8 to 13 (p = 0.001) in PC-ineligible patients. In 1017 patients regardless of PC eligibility, 5-year CSM-free survival rate was 65.6%, and PLND extent predicted lower CSM (multivariable hazard ratio [mHR]: 0.99, p = 0.036). In 197 PC-eligible patients, 5-year CSM-free survival rate was 84.2%, and the PLND extent was not associated with CSM (mHR: 0.96, p = 0.2). Conversely, in 820 PC-ineligible patients, 5-year CSM-free survival rate was 61.1%, and PLND extent predicted lower CSM (mHR: 0.99, p = 0.043).</p><p><strong>Conclusion: </strong>In all PC patients regardless of eligibility status, more extensive PLND was associated with improved cancer-specific survival.</p>","PeriodicalId":14323,"journal":{"name":"International Journal of Urology","volume":"33 5","pages":"e70483"},"PeriodicalIF":2.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13135126/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147815080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Comment on Optimizing Patient Selection for Aquablation During the Initial Adoption Phase: Prostate Smaller Than 100 mL. 在初始采用阶段优化水消融患者选择:前列腺小于100 mL。
IF 2.2 3区 医学
International Journal of Urology Pub Date : 2026-05-01 DOI: 10.1111/iju.70467
Taiki Kato
{"title":"Editorial Comment on Optimizing Patient Selection for Aquablation During the Initial Adoption Phase: Prostate Smaller Than 100 mL.","authors":"Taiki Kato","doi":"10.1111/iju.70467","DOIUrl":"https://doi.org/10.1111/iju.70467","url":null,"abstract":"","PeriodicalId":14323,"journal":{"name":"International Journal of Urology","volume":"33 5","pages":"e70467"},"PeriodicalIF":2.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147837716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stage-Dependent Changes in Kynurenine Pathway Enzyme Expression Suggest Immune-Related Involvement in Bladder Cancer Progression. 犬尿氨酸途径酶表达的阶段依赖性变化提示膀胱癌进展中免疫相关的参与。
IF 2.2 3区 医学
International Journal of Urology Pub Date : 2026-05-01 DOI: 10.1111/iju.70491
Douglas Edgard Lemes, Aline Áurea de Souza Santos, Jéssica Lopes de Oliveira, Henrique Roman-Ramos, Ana Carolina Ramos Moreno, Cleber Pinto Camacho, José Pontes-Junior, Humberto Dellê
{"title":"Stage-Dependent Changes in Kynurenine Pathway Enzyme Expression Suggest Immune-Related Involvement in Bladder Cancer Progression.","authors":"Douglas Edgard Lemes, Aline Áurea de Souza Santos, Jéssica Lopes de Oliveira, Henrique Roman-Ramos, Ana Carolina Ramos Moreno, Cleber Pinto Camacho, José Pontes-Junior, Humberto Dellê","doi":"10.1111/iju.70491","DOIUrl":"10.1111/iju.70491","url":null,"abstract":"<p><p>L-tryptophan (Trp) metabolism through the L-kynurenine (Kyn) pathway contributes to immune escape in neoplasms, including bladder cancer (BC). Indoleamine 2,3-dioxygenase-1 (IDO1) is a key enzyme, and its catabolites-Kyn, 3-hydroxykynurenine (3HK), and 3-hydroxyanthranilate (3HAA)-depend on other enzymes and play a crucial role in immunomodulation.</p><p><strong>Objectives: </strong>We investigated the association between Kyn pathway enzyme expression and BC prognostic factors.</p><p><strong>Methods: </strong>Data from 165 bc patients in the GEO DataSets were analyzed, comparing staging, tumor grade, progression, and recurrence with the expression of IDO1, arylformamidase (AFMID), kynurenine-oxoglutarate transaminase (KAT), kynureninase (KYNU), kynurenine 3-monooxygenase (KMO), 3-hydroxyanthranilate 3,4-dioxygenase (HAAO), and aminocarboxymuconate-semialdehyde decarboxylase (ACMSD). Predictive genes were further evaluated in RT4 (low-grade, non-invasive) and T24 (high-grade, invasive) BC cells treated with IFN-gamma and the IDO1 inhibitor INCB024360. Trp catabolites were quantified in the supernatant.</p><p><strong>Results: </strong>Enzyme expression varied widely, especially for IDO1, AFMID, KAT, KMO, and KYNU. IDO1 correlated positively with KMO and negatively with KAT. High IDO1 and KMO levels were linked to advanced-stage disease, while KAT and KYNU were associated with earlier stages and lower tumor grade. RT4 and T24 cells showed distinct basal enzyme expression, with T24 cells being more responsive to IFN-gamma, increasing IDO1 and KYNU while decreasing KAT and KMO. These effects were inhibited by INCB024360. High Trp consumption increased Kyn and 3HAA but not 3HK.</p><p><strong>Conclusions: </strong>Kyn pathway enzyme expression varies with disease progression and may indicate immune activity by influencing tumor microenvironment catabolites. BC cell sensitivity to immune stimuli differs, potentially shaping distinct immune escape mechanisms.</p>","PeriodicalId":14323,"journal":{"name":"International Journal of Urology","volume":"33 5","pages":"e70491"},"PeriodicalIF":2.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13150956/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147837650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Comment to "Prognostic Significance of Hypoalbuminemia in Maintenance Avelumab Therapy After First-Line Chemotherapy for Metastatic Urothelial Carcinoma: A Multicenter Real-World Study (YUSHIMA Study)". 对“低白蛋白血症在转移性尿路上皮癌一线化疗后维持阿维单抗治疗中的预后意义:一项多中心真实世界研究(YUSHIMA研究)”的社论评论。
IF 2.2 3区 医学
International Journal of Urology Pub Date : 2026-05-01 DOI: 10.1111/iju.70490
Nozomi Hayakawa, Eiji Kikuchi
{"title":"Editorial Comment to \"Prognostic Significance of Hypoalbuminemia in Maintenance Avelumab Therapy After First-Line Chemotherapy for Metastatic Urothelial Carcinoma: A Multicenter Real-World Study (YUSHIMA Study)\".","authors":"Nozomi Hayakawa, Eiji Kikuchi","doi":"10.1111/iju.70490","DOIUrl":"https://doi.org/10.1111/iju.70490","url":null,"abstract":"","PeriodicalId":14323,"journal":{"name":"International Journal of Urology","volume":"33 5","pages":"e70490"},"PeriodicalIF":2.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147814991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书